In cases where surgery is carried out using an extracorporeal circulation system (heart-lung machine) or autotransfusion devices, extra care must be taken to prevent STARSIL® HEMOSTAT particles from entering the bloodstream. The use of a 40μ cardiotomy reservoir, cell washing, and a 40μ transfusion filter, for example, is necessary in this case.
The STARSIL® HEMOSTAT powder must be kept dry before use. Liquids and moist environments cause a reduction in the hemostatic effect and can even cancel it out completely.
STARSIL® HEMOSTAT is not suitable for the primary treatment of coagulation disorders.
The use of STARSIL® HEMOSTAT in combination with other hemostatic agents has not been clinically tested. No experience has been gained as yet with regard to reciprocal effects between STARSIL® HEMOSTAT and the various types of adhesive and bone cement used to anchor prostheses in bone. To avoid any impairment of the bonding and binding of any product or device with the bone, all particles of STARSIL® HEMOSTAT must be removed completely from the surface of the bone before the adhesive or cement is applied.